학술논문
Clinical Experience in the Randomized Phase 3 Sierra Trial: Anti-CD45 Iodine (I-131) Apamistamab [Iomab-B] Conditioning Enables Hematopoietic Cell Transplantation with Successful Engraftment and Acceptable Safety in Patients with Active, Relapsed/Refractory AML Not Responding to Targeted Therapies
Document Type
Journal
Author
Gyurkocza, Boglarka; Nath, Rajneesh; Seropian, Stuart; Choe, Hannah; Litzow, Mark R.; Koshy, Nebu V.; Stiff, Patrick; Abboud, Camille, Sr.; Tomlinson, Benjamin; Abhyankar, Sunil; Hari, Parameswaran; Al-Kadhimi, Zaid S.; Chen, George L.; Sabloff, Mitchell; Orozco, Johnnie J.; Foran, James M.; Kebriaei, Partow; Jamieson, Katarzyna Joanna; Magalhaes-Silverman, Margarida Magalhaes; van Besien, Koen; Schuster, Michael W.; Law, Arjun; Levy, Moshe; Lazarus, Hillard M.; Giralt, Sergio A.; Berger, Mark S.; Spross, Jennifer A.; Desai, Avinash G.; Reddy, Vijay; Pagel, John M.
Source
Subject
Language
English
ISSN
15280020